Cargando…
SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment
Synthetic lethality exploits the phenomenon that a mutation in a cancer gene is often associated with new vulnerability which can be uniquely targeted therapeutically, leading to a significant increase in favorable outcome. DNA damage and survival pathways are among the most commonly mutated network...
Autores principales: | Deng, Xiang, Das, Shaoli, Valdez, Kristin, Camphausen, Kevin, Shankavaram, Uma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895978/ https://www.ncbi.nlm.nih.gov/pubmed/31671773 http://dx.doi.org/10.3390/cancers11111682 |
Ejemplares similares
-
Glioma-BioDP: database for visualization of molecular profiles to improve prognosis of brain cancer
por: Deng, Xiang, et al.
Publicado: (2023) -
Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP
por: Celiku, Orieta, et al.
Publicado: (2014) -
Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response
por: Das, Shaoli, et al.
Publicado: (2019) -
Synthetic Lethal Drug Combinations Targeting Proteasome and Histone Deacetylase Inhibitors in TP53-Mutated Cancers
por: Das, Shaoli, et al.
Publicado: (2020) -
Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
por: Das, Shaoli, et al.
Publicado: (2020)